Prospective Treatment Efficacy in IPF Using Genotype for Nac Selection (PRECISIONS) Trial (PRECISIONS)
Sponsor: Fernando J Martinez
This PHASE3 trial investigates Idiopathic Pulmonary Fibrosis and is currently ongoing. Fernando J Martinez leads this study, which shows 18 recorded versions since 2020 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
18 versions recorded-
Jun 2025 — Present [monthly]
Active Not Recruiting PHASE3
-
Jan 2025 — Jun 2025 [monthly]
Active Not Recruiting PHASE3
-
Sep 2024 — Jan 2025 [monthly]
Active Not Recruiting PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Active Not Recruiting PHASE3
-
Mar 2024 — Jul 2024 [monthly]
Active Not Recruiting PHASE3
Status: Recruiting → Active Not Recruiting
▶ Show 13 earlier versions
-
Apr 2023 — Mar 2024 [monthly]
Recruiting PHASE3
-
Feb 2023 — Apr 2023 [monthly]
Recruiting PHASE3
-
Sep 2022 — Feb 2023 [monthly]
Recruiting PHASE3
-
Jun 2022 — Sep 2022 [monthly]
Recruiting PHASE3
-
Mar 2022 — Jun 2022 [monthly]
Recruiting PHASE3
-
Feb 2022 — Mar 2022 [monthly]
Recruiting PHASE3
-
Oct 2021 — Feb 2022 [monthly]
Recruiting PHASE3
-
Sep 2021 — Oct 2021 [monthly]
Recruiting PHASE3
-
Feb 2021 — Sep 2021 [monthly]
Recruiting PHASE3
-
Jan 2021 — Feb 2021 [monthly]
Recruiting PHASE3
Status: Not Yet Recruiting → Recruiting
-
Dec 2020 — Jan 2021 [monthly]
Not Yet Recruiting PHASE3
-
Jun 2020 — Dec 2020 [monthly]
Not Yet Recruiting PHASE3
-
Apr 2020 — Jun 2020 [monthly]
Not Yet Recruiting PHASE3
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Fernando J Martinez
- National Heart, Lung, and Blood Institute (NHLBI)
- Pulmonary Fibrosis Foundation
- Three Lakes Foundation
- University of Michigan
- University of Virginia
- University of Washington
For direct contact, visit the study record on ClinicalTrials.gov .